Skoumal S M, Maygarden S J
Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska 68131, USA.
Mod Pathol. 1997 Mar;10(3):267-9.
The malpractice claims activity in anatomic pathology has sharply increased in recent years. On a relative and absolute basis, a leading area of increase for claims is cervicovaginal (Pap smear) cytology. As never before, pathologists are faced with the threat of litigation and acting as defendants in medical-legal actions. Defending claims of malpractice in Pap smear litigation can be difficult. The expert witness for the plaintiff often performs a selective retrospective review of the Pap smear of the plaintiff, compared with the screening examination performed by the defendant. In addition, it is unclear whether atypical or dysplastic cells are within the standard of practice and should be discovered by the Pap smear screener. A proposal for a forum to develop guidelines for expert witness testimony in Pap smear cytology is discussed.
近年来，解剖病理学中的医疗事故索赔活动急剧增加。从相对和绝对的角度来看，索赔增加的一个主要领域是宫颈阴道（巴氏涂片）细胞学。病理学家前所未有的面临诉讼威胁，并在医疗法律诉讼中作为被告。在巴氏涂片诉讼中为医疗事故索赔进行辩护可能很困难。原告的专家证人通常会对原告的巴氏涂片进行选择性回顾性审查，并与被告进行的筛查检查进行比较。此外，目前尚不清楚非典型或发育异常细胞是否在执业标准范围内，以及是否应由巴氏涂片筛查人员发现。本文讨论了关于建立一个论坛以制定巴氏涂片细胞学专家证人证言指南的提议。
